QQ客服 官方微博 反馈留言

	REAL-WORLD EVIDENCE FOR CLINICAL EFFECTIVENESS, TOXICITY, AND HOSPITALIZATION COSTS ASSOCIATED WITH SECOND-LINE CHEMOTHERAPY IN CHINESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
	Hu, Cheng Ping; Wang, Yan; Chen, Jianhua; Wu, Shengqi; Li, Xiaoling; Wang, Yuqin; Yang, Yicheng; Rajan, Narayan; Papadimitropoulos, Manny; Xiao, Qiong
	2013
卷号	8页码:S587-S588
关键词	adverse event Cost second-line chemotherapy non-squamous NSCLC
ISSN号	1556-0864
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6706431
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Hu, Cheng Ping,Wang, Yan,Chen, Jianhua,et al. REAL-WORLD EVIDENCE FOR CLINICAL EFFECTIVENESS, TOXICITY, AND HOSPITALIZATION COSTS ASSOCIATED WITH SECOND-LINE CHEMOTHERAPY IN CHINESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER[J],2013,8:S587-S588.
APA	Hu, Cheng Ping.,Wang, Yan.,Chen, Jianhua.,Wu, Shengqi.,Li, Xiaoling.,...&Chen, Wendong.(2013).REAL-WORLD EVIDENCE FOR CLINICAL EFFECTIVENESS, TOXICITY, AND HOSPITALIZATION COSTS ASSOCIATED WITH SECOND-LINE CHEMOTHERAPY IN CHINESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER.,8,S587-S588.
MLA	Hu, Cheng Ping,et al."REAL-WORLD EVIDENCE FOR CLINICAL EFFECTIVENESS, TOXICITY, AND HOSPITALIZATION COSTS ASSOCIATED WITH SECOND-LINE CHEMOTHERAPY IN CHINESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER".8(2013):S587-S588.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。